| Filed On | Filing |
|---|---|
| 11 Oct 2023 |
Form 3: Ray Sumita, Chief Legal Officer, Secretary
No securities owned |
| 10 Feb 2023 |
Form 3: Toledano Gabrielle B, Director
No securities owned |
| 10 Feb 2023 |
Form 3: Eade Katherine A., Director
No securities owned |
| 10 Feb 2023 |
Form 3: Smith James Alan, Director
Holds 8,058 shares of Class A common stock |
| 10 Feb 2023 |
Form 3: Ogilvie Landon E, Director
Holds 32,850 shares of Class A common stock |
| 04 Apr 2022 |
Form 3: Powchik Peter, Director
Holds 225,858 shares of Class A common stock |
| 11 Jan 2022 |
Form 3: Pesile Jason, See Remarks
No securities owned |
| 05 Jan 2022 |
Form 3: Hornig George R, Director
No securities owned |
| 10 Nov 2021 | Form 3: Paula Molina Rene, See Remarks |
| 10 Nov 2021 |
Form 3: United Biomedical Inc, 10% owner
Holds 51,338,366 shares of Class A common stock |
| 10 Nov 2021 | Form 3: Guirakhoo Farshad, Chief Scientific Officer |
| 10 Nov 2021 |
Form 3: Doran Martin, See Remarks
Holds 22,688 shares of Class A common stock |
| 10 Nov 2021 | Form 3: Blatt Gregory R, Director |
| 10 Nov 2021 |
Form 3: Palm Ulo, Chief Medical Officer
No securities owned |
| 10 Nov 2021 |
Form 3: Hu Mei Mei, Director
Holds 51,338,366 shares of Class A common stock |
| 10 Nov 2021 |
Form 3: Reese Lou, Director
Holds 51,338,366 shares of Class A common stock |
| 10 Nov 2021 | Form 3: Chui James, Director |
| 10 Nov 2021 |
Form 3: Diamandis Peter, Director
Holds 1,099,915 shares of Class B common stock |
| 10 Nov 2021 | Form 3: Prime Movers Lab Fund I Lp, 10% owner and 1 other |
Loading...